/PRNewswire/ Stämm, a pioneering biotechnology company, is delighted to announce the appointment of Stefan Oschmann, PhD. as an independent director on its.
Larry Edwards brings more than two decades of experience in executive and commercial leadership roles in the anti-infective space at both biotechnology and large pharmaceutical companiesAiCuris establishes
Investegate announcements from European Healthcare Acquisitio, European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH signed Business Combination Agreement